Status:
COMPLETED
Efficacy of Combined Treatment for Young Bipolar I Disorder
Lead Sponsor:
University of Sao Paulo
Conditions:
Bipolar I Disorder
Eligibility:
All Genders
18-35 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine the efficacy of the combination of lithium and carbamazepine compared with lithium and valproate treating young bipolar patients.
Detailed Description
After the diagnostic assessments, the patients are allocated for one of the following groups of treatment: Group I: lithium + valproic acid Group II: lithium + carbamazepine Patients will be follow...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Bipolar Disorder, type I, in current episode (manic/hypomanic, mixed or depression)
- The patient or his (her) legal representative should understand the nature of the study and sign the Informed Consent.
Exclusion
- Schizophrenia or schizoaffective disorder
- Mental retardation
- Unstable clinical diseases
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00976794
Start Date
January 1 2009
End Date
June 1 2012
Last Update
July 12 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Psychiatry - University of São Paulo
São Paulo, São Paulo, Brazil